Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -4.24% is 68% above its 5-year average of -13.06%, near the high end of its 5-year range (-2156.43%–24.07%).
37.28% above its 12-month average of -6.76%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 9.06%.
OPERATING MARGIN
-4.24%
OPERATING MARGIN AVG TTM
-6.76%
OPERATING MARGIN AVG 3Y
-11.59%
OPERATING MARGIN AVG 5Y
-13.06%
OPERATING MARGIN AVG 10Y
4.02%
OPERATING MARGIN AVG 15Y
16.68%
OPERATING MARGIN AVG 20Y
17.52%
CURRENT VS TTM AVG
+37.28%
CURRENT VS 3Y AVG
+63.42%
CURRENT VS 5Y AVG
+67.55%
CURRENT VS 10Y AVG
-205.38%
CURRENT VS 15Y AVG
-125.42%
CURRENT VS 20Y AVG
-124.20%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Anika Therapeutics, Inc.
Market Cap
$264.05M
Operating Margin
-4.24%
TTM Avg
-6.76%
3Y Avg
-11.59%
5Y Avg
-13.06%
Market Cap
$264.07M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-5599.55%
5Y Avg
-3879.66%
Market Cap
$264.10M
Operating Margin
-775.98%
TTM Avg
-556.52%
3Y Avg
-379.20%
5Y Avg
-295.79%
Market Cap
$267.99M
Operating Margin
-13.78%
TTM Avg
-1055.13%
3Y Avg
-2810.33%
5Y Avg
-1873.55%
Market Cap
$259.30M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$275.81M
Operating Margin
-1927.32%
TTM Avg
-1059.56%
3Y Avg
-1070.46%
5Y Avg
-779.81%
Market Cap
$276.26M
Operating Margin
-14.55%
TTM Avg
-6.56%
3Y Avg
-30.72%
5Y Avg
-57.13%
Market Cap
$251.64M
Operating Margin
-1488.31%
TTM Avg
-4815.32%
3Y Avg
-6115.40%
5Y Avg
-4078.06%
Market Cap
$248.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | $264.05M | -4.24% | -6.76% | -11.59% | -13.06% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $264.07M | 0.00% | 0.00% | -5599.55% | -3879.66% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $264.10M | -775.98% | -556.52% | -379.20% | -295.79% |
| Century Therapeutics, Inc. (IPSC)vs › | $267.99M | -13.78% | -1055.13% | -2810.33% | -1873.55% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| AC Immune S.A. (ACIU)vs › | $275.81M | -1927.32% | -1059.56% | -1070.46% | -779.81% |
| Aurora Cannabis Inc. (ACB)vs › | $276.26M | -14.55% | -6.56% | -30.72% | -57.13% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $251.64M | -1488.31% | -4815.32% | -6115.40% | -4078.06% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $248.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| InflaRx N.V. (IFRX)vs › | $247.45M | -164525.50% | -98218.45% | -66780.63% | -44520.42% |
Gross Margin
62.2%
Operating Margin
-4.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 9.06% |
| 2026-03-31 | -18.53% |
| 2025-12-31 | 2.11% |
| 2025-09-30 | -11.62% |
| 2025-06-30 | -14.81% |
| 2025-03-31 | -16.37% |
| 2024-12-31 | -2156.43% |
| 2024-09-30 | -72.30% |
| 2024-06-30 | -5.89% |
| 2024-03-31 | -12.49% |
| 2023-12-31 | -148.43% |
| 2023-09-30 | -18.51% |
| 2023-06-30 | -8.20% |
| 2023-03-31 | -33.10% |
| 2022-12-31 | -16.83% |
| 2022-09-30 | -14.40% |
| 2022-06-30 | -8.53% |
| 2022-03-31 | -9.69% |
| 2021-12-31 | -25.47% |
| 2021-09-30 | 3.29% |
| 2021-06-30 | 24.07% |
| 2021-03-31 | 3.67% |
| 2020-12-31 | -54.92% |
| 2020-09-30 | -25.01% |
| 2020-06-30 | -31.08% |
| 2020-03-31 | 20.04% |
| 2019-12-31 | 16.13% |
| 2019-09-30 | 40.57% |
| 2019-06-30 | 39.17% |
| 2019-03-31 | 22.17% |
| 2018-12-31 | 36.21% |
| 2018-09-30 | 32.00% |
| 2018-06-30 | 36.81% |
| 2018-03-31 | -36.83% |
| 2017-12-31 | 33.10% |
| 2017-09-30 | 37.78% |
| 2017-06-30 | 52.97% |
| 2017-03-31 | 34.23% |
| 2016-12-31 | 44.35% |
| 2016-09-30 | 53.08% |
| 2016-06-30 | 50.67% |
| 2016-03-31 | 48.06% |
| 2015-12-31 | 55.23% |
| 2015-09-30 | 55.47% |
| 2015-06-30 | 54.27% |
| 2015-03-31 | 35.47% |
| 2014-12-31 | 51.98% |
| 2014-09-30 | 46.64% |
| 2014-06-30 | 57.86% |
| 2014-03-31 | 70.19% |
| 2013-12-31 | 49.08% |
| 2013-09-30 | 43.74% |
| 2013-06-30 | 45.12% |
| 2013-03-31 | 32.87% |
| 2012-12-31 | 34.47% |
| 2012-09-30 | 18.47% |
| 2012-06-30 | 31.26% |
| 2012-03-31 | 21.33% |
| 2011-12-31 | 26.65% |
| 2011-09-30 | 26.10% |
| 2011-06-30 | 22.78% |
| 2011-03-31 | 4.74% |
| 2010-12-31 | 16.83% |
| 2010-09-30 | 14.98% |
| 2010-06-30 | 12.44% |
| 2010-03-31 | 9.45% |
| 2009-12-31 | 15.10% |
| 2009-09-30 | 18.68% |
| 2009-06-30 | 12.68% |
| 2009-03-31 | 8.25% |
| 2008-12-31 | 13.93% |
| 2008-09-30 | 14.46% |
| 2008-06-30 | 9.83% |
| 2008-03-31 | 8.84% |
| 2007-12-31 | 22.03% |
| 2007-09-30 | 23.61% |
| 2007-06-30 | 19.21% |
| 2007-03-31 | 19.92% |
| 2006-12-31 | 14.78% |
| 2006-09-30 | 27.69% |
| 2006-06-30 | 23.09% |
| 2006-03-31 | 14.95% |
| 2005-12-31 | 15.70% |
| 2005-09-30 | 38.96% |
| 2005-06-30 | 28.02% |
| 2005-03-31 | 24.77% |
| 2004-12-31 | 31.14% |
| 2004-09-30 | 23.58% |
| 2004-06-30 | 20.57% |
| 2004-03-31 | 19.62% |
| 2003-12-31 | 16.63% |
| 2003-09-30 | 10.60% |
| 2003-06-30 | -3.65% |
| 2003-03-31 | -15.04% |
| 2002-12-31 | 14.74% |
| 2002-09-30 | -24.71% |
